Release Date: 15/05/14 12:39 Summary: Reinstatement to Official Quotation - 16 May 2014 Price Sensitive: Yes Download Document 21.76KB Download
MSB Mesoblast resubmits US FDA application for approval of Ryoncil in children with graft vs host disease; shares dip -4%